264 related articles for article (PubMed ID: 16254965)
1. Antigenicity and immunogenicity of the immunodominant region of hepatitis B surface antigen displayed on bacteriophage T7.
Tan GH; Yusoff K; Seow HF; Tan WS
J Med Virol; 2005 Dec; 77(4):475-80. PubMed ID: 16254965
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
3. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
4. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen.
Shiau AL; Murray K
J Med Virol; 1997 Mar; 51(3):159-66. PubMed ID: 9139078
[TBL] [Abstract][Full Text] [Related]
5. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
Bremer CM; Sominskaya I; Skrastina D; Pumpens P; El Wahed AA; Beutling U; Frank R; Fritz HJ; Hunsmann G; Gerlich WH; Glebe D
J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866
[TBL] [Abstract][Full Text] [Related]
6. A mimotope of pre-S2 region of surface antigen of viral hepatitis B screened by phage display.
Zhang WY; Wan Y; Li DG; Tang Y; Zhou W
Cell Res; 2001 Sep; 11(3):203-8. PubMed ID: 11642405
[TBL] [Abstract][Full Text] [Related]
7. Behavior of a short preS1 epitope on the surface of hepatitis B core particles.
Borisova G; Borschukova O; Skrastina D; Dislers A; Ose V; Pumpens P; Grens E
Biol Chem; 1999 Mar; 380(3):315-24. PubMed ID: 10223334
[TBL] [Abstract][Full Text] [Related]
8. The amino Acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen.
Tian Y; Xu Y; Zhang Z; Meng Z; Qin L; Lu M; Yang D
J Clin Microbiol; 2007 Sep; 45(9):2971-8. PubMed ID: 17609325
[TBL] [Abstract][Full Text] [Related]
9. Display of hepatitis B virus PreS1 peptide on bacteriophage T7 and its potential in gene delivery into HepG2 cells.
Tang KH; Yusoff K; Tan WS
J Virol Methods; 2009 Aug; 159(2):194-9. PubMed ID: 19490973
[TBL] [Abstract][Full Text] [Related]
10. A phage-displayed cyclic peptide that interacts tightly with the immunodominant region of hepatitis B surface antigen.
Tan WS; Tan GH; Yusoff K; Seow HF
J Clin Virol; 2005 Sep; 34(1):35-41. PubMed ID: 16087122
[TBL] [Abstract][Full Text] [Related]
11. Reduced antigenicity of naturally occurring hepatitis B surface antigen variants with substitutions at the amino acid residue 126.
Qiu S; Zhang J; Tian Y; Yang Y; Huang H; Yang D; Lu M; Xu Y
Intervirology; 2008; 51(6):400-6. PubMed ID: 19258718
[TBL] [Abstract][Full Text] [Related]
12. Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen.
Desombere I; Willems A; Gijbels Y; Leroux-Roels G
J Virol; 2006 Apr; 80(7):3506-14. PubMed ID: 16537618
[TBL] [Abstract][Full Text] [Related]
13. Optimisation of secretion of recombinant HBsAg virus-like particles: Impact on the development of HIV-1/HBV bivalent vaccines.
Michel M; Lone YC; Centlivre M; Roux P; Wain-Hobson S; Sala M
Vaccine; 2007 Feb; 25(10):1901-11. PubMed ID: 17005303
[TBL] [Abstract][Full Text] [Related]
14. Viral and clinical factors associated with surface gene variants among hepatitis B virus carriers.
Roque-Afonso AM; Férey MP; Ly TD; Graube A; Costa-Faria L; Samuel D; Dussaix E
Antivir Ther; 2007; 12(8):1255-63. PubMed ID: 18240865
[TBL] [Abstract][Full Text] [Related]
15. A unique amino acid substitution, T126I, in human genotype C of hepatitis B virus S gene and its possible influence on antigenic structural change.
Ren F; Tsubota A; Hirokawa T; Kumada H; Yang Z; Tanaka H
Gene; 2006 Nov; 383():43-51. PubMed ID: 16963200
[TBL] [Abstract][Full Text] [Related]
16. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
[TBL] [Abstract][Full Text] [Related]
17. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
Li X; Yang X; Li L; Liu H; Liu J
Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
[TBL] [Abstract][Full Text] [Related]
18. [Construction and characterization of hepatitis B surface antigen "a" epitope virus-like particles].
Chen SY; Guo MZ; Qiu F; Fei YL; Yi Y; Guo Y; Jia ZY; Yu T; Bi SL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):30-2. PubMed ID: 20848844
[TBL] [Abstract][Full Text] [Related]
19. Definition of the primary structure of hepatitis B virus (HBV) pre-S hepatocyte binding domain using random peptide libraries.
D'Mello F; Partidos CD; Steward MW; Howard CR
Virology; 1997 Oct; 237(2):319-26. PubMed ID: 9356343
[TBL] [Abstract][Full Text] [Related]
20. An hepatitis B virus surface antigen specific single chain of variable fragment derived from a natural immune antigen binding fragment phage display library is specifically internalized by HepG2.2.15 cells.
Wen WH; Qin WJ; Gao H; Zhao J; Jia LT; Liao QH; Meng YL; Jin BQ; Yao LB; Chen SY; Yang AG
J Viral Hepat; 2007 Jul; 14(7):512-9. PubMed ID: 17576393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
